Simcere Pharmaceutical
Simcere Pharmaceutical Co., Ltd., a Chinese firm, manufactures human and veterinary pharmaceuticals since 1993.
Founded
1995Simcere Pharmaceutical Co., Ltd., a Chinese firm, manufactures human and veterinary pharmaceuticals since 1993.
Simcere Pharmaceutical Co., Ltd., founded in 1993, is a Chinese company dedicated to manufacturing pharmaceuticals for human and veterinary use. The company's core mission is to provide patients with more effective medications, focusing on innovative treatments in areas such as oncology, neurology, autoimmune diseases, cardiovascular, and anti-infection. Simcere aims to advance healthcare by developing and commercializing cutting-edge drugs that address unmet medical needs.
Notable figures associated with Simcere include its leadership team and key investors who have supported the company's growth and innovation. The company has achieved significant milestones, such as the inclusion of its insomnia drug in the 2023 edition of China's Adult Insomnia Diagnosis and Treatment Guidelines and presenting clinical research at major conferences like ASCO. Simcere's impact is evident in its contribution to improving patient outcomes through its innovative pharmaceutical solutions.
Companies similar to Simcere Pharmaceutical include Betta Pharmaceuticals Co., Sino Biopharmaceutical, Haisco and Collegium Pharmaceutical.
Simcere Pharmaceutical was founded in 1995.
Simcere Pharmaceutical's headquarters is located in Nanjing, Jiangsu, CN.
Simcere Pharmaceutical's most recent funding round was for CN¥600M (CNY) in June 2021.
As of Jun 4, 2021, Simcere Pharmaceutical has disclosed funding of CN¥600M (CNY). Undisclosed round amounts are excluded.
Simcere Pharmaceutical has 7,832 employees as of Feb 6, 2024.
Collegium Pharmaceutical
